Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanni Xu

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Journal of Neuroinflammation|November 7, 2025
Fatty acid-binding protein 4 drives microglia-mediated neuroinflammation through promoting S100A9 expression and lipid droplet accumulation after intracerebral hemorrhageJiaqing He, Zijuan Qin, Haixiao Liu, et al.
Biochemical and Biophysical Research Communications|March 11, 2018
A novel SIRT1 activator E6155 improves insulin sensitivity in type 2 diabetic KKA<sub>y</sub> micePeng Liu, Tingting Feng, Xuan Zuo, et al.
Cell Death & Disease|June 2, 2017
RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotionYanni Xu, Liang Chu, Sujing Yuan, et al.
Experimental Dermatology|January 27, 2010
Increased expression of MAP2 inhibits melanoma cell proliferation, invasion and tumor growth in vitro and in vivoZhiqi Song, Chun-Di He, Changkai Sun, et al.
Biochemical and Biophysical Research Communications|October 19, 2011
Mycophenolic acid induces ATP-binding cassette transporter A1 (ABCA1) expression through the PPARγ-LXRα-ABCA1 pathwayYanni Xu, Fangfang Lai, Yang Xu, et al.
Biological & Pharmaceutical Bulletin|October 4, 2011
Two thiophenes compounds are partial peroxisome proliferator-activated receptor α/γ dual agonistsZhihui Zheng, Yi Yang, Huayi Shao, et al.
International Journal of Molecular Sciences|December 30, 2025
A Novel RANKL/RANK Inhibitor IMB-R38 Inhibits Osteoporosis Through Regulating Bone MetabolismYuyan Zhang, Xinwei Wei, Ren Sheng, et al.
Current Issues in Molecular Biology|June 27, 2023
SIRT1 Activator E1231 Alleviates Nonalcoholic Fatty Liver Disease by Regulating Lipid MetabolismJiangxue Han, Shunwang Li, Weizhi Wang, et al.
Frontiers in Pharmacology|January 14, 2021
Nuclear Factor Erythroid 2 Related Factor 2 Activator JC-5411 Inhibits Atherosclerosis Through Suppression of Inflammation and Regulation of Lipid MetabolismXinhai Jiang, Yining Li, Weizhi Wang, et al.
Atherosclerosis|May 23, 2018
SIRT1 activator E1231 protects from experimental atherosclerosis and lowers plasma cholesterol and triglycerides by enhancing ABCA1 expressionTingting Feng, Peng Liu, Xiao Wang, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Journal of Neuroinflammation|November 7, 2025
Fatty acid-binding protein 4 drives microglia-mediated neuroinflammation through promoting S100A9 expression and lipid droplet accumulation after intracerebral hemorrhageJiaqing He, Zijuan Qin, Haixiao Liu, et al.
Biochemical and Biophysical Research Communications|March 11, 2018
A novel SIRT1 activator E6155 improves insulin sensitivity in type 2 diabetic KKA<sub>y</sub> micePeng Liu, Tingting Feng, Xuan Zuo, et al.
Cell Death & Disease|June 2, 2017
RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotionYanni Xu, Liang Chu, Sujing Yuan, et al.
Experimental Dermatology|January 27, 2010
Increased expression of MAP2 inhibits melanoma cell proliferation, invasion and tumor growth in vitro and in vivoZhiqi Song, Chun-Di He, Changkai Sun, et al.
Biochemical and Biophysical Research Communications|October 19, 2011
Mycophenolic acid induces ATP-binding cassette transporter A1 (ABCA1) expression through the PPARγ-LXRα-ABCA1 pathwayYanni Xu, Fangfang Lai, Yang Xu, et al.
Biological & Pharmaceutical Bulletin|October 4, 2011
Two thiophenes compounds are partial peroxisome proliferator-activated receptor α/γ dual agonistsZhihui Zheng, Yi Yang, Huayi Shao, et al.
International Journal of Molecular Sciences|December 30, 2025
A Novel RANKL/RANK Inhibitor IMB-R38 Inhibits Osteoporosis Through Regulating Bone MetabolismYuyan Zhang, Xinwei Wei, Ren Sheng, et al.
Current Issues in Molecular Biology|June 27, 2023
SIRT1 Activator E1231 Alleviates Nonalcoholic Fatty Liver Disease by Regulating Lipid MetabolismJiangxue Han, Shunwang Li, Weizhi Wang, et al.
Frontiers in Pharmacology|January 14, 2021
Nuclear Factor Erythroid 2 Related Factor 2 Activator JC-5411 Inhibits Atherosclerosis Through Suppression of Inflammation and Regulation of Lipid MetabolismXinhai Jiang, Yining Li, Weizhi Wang, et al.
Atherosclerosis|May 23, 2018
SIRT1 activator E1231 protects from experimental atherosclerosis and lowers plasma cholesterol and triglycerides by enhancing ABCA1 expressionTingting Feng, Peng Liu, Xiao Wang, et al.
Pageof 9